Terms: = Cervical cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Treatment
29 results:
1. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
2. Resveratrol against cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
3. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of cervical cancer in a Subcutaneous Xenograft Mouse Model.
Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
[TBL] [Abstract] [Full Text] [Related]
4. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
Amran N; Abdul-Rahman PS
J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
[TBL] [Abstract] [Full Text] [Related]
5. Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
Baeten IGT; Hoogendam JP; Jonges GN; Jürgenliemk-Schulz IM; Braat AJAT; van Diest PJ; Gerestein CG; Zweemer RP
Gynecol Oncol; 2022 May; 165(2):257-263. PubMed ID: 35219527
[TBL] [Abstract] [Full Text] [Related]
6. A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent cervical cancer After Failure of First-Line Therapy.
Yang H; Sun S; Mei Z; Xiang Q; Yang C; Chen M; Xie C; Zhou Y; Qiu H
Drug Des Devel Ther; 2021; 15():4665-4674. PubMed ID: 34815663
[TBL] [Abstract] [Full Text] [Related]
7. Anti-tumour effect of in situ vaccines combined with vegfr inhibitors in the treatment of metastatic cervical cancer.
Liu L; Cai L; Du X; Zhao J; Zhao Y; Zou C; Yu S; Zhang C; Ye P; Su X; Yan X; Li W
Int Immunopharmacol; 2021 Dec; 101(Pt B):108302. PubMed ID: 34717193
[TBL] [Abstract] [Full Text] [Related]
8. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
9. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract] [Full Text] [Related]
10. Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway.
Zhang X; Wang Y; Wang X; Zou B; Mei J; Peng X; Wu Z
Cancer Gene Ther; 2021 May; 28(5):529-542. PubMed ID: 33235271
[TBL] [Abstract] [Full Text] [Related]
11. HIV Protease Inhibitors Block HPV16-Induced Murine cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Qiu Y; Maione F; Capano S; Meda C; Picconi O; Brundu S; Pisacane A; Sapino A; Palladino C; Barillari G; Monini P; Bussolino F; Ensoli B; Sgadari C; Giraudo E
Mol Cancer Ther; 2020 Dec; 19(12):2476-2489. PubMed ID: 33082275
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Efficacy and Safety of Apatinib for the treatment of Patients with Metastatic, Recurrent cervical cancer after Failure of Radiotherapy and First-Line Chemotherapy: A Prospective Study.
Xia X; Jiang W; Qi W; Hong B; Zhao W
Oncol Res Treat; 2020; 43(12):649-655. PubMed ID: 33045704
[TBL] [Abstract] [Full Text] [Related]
13. cervical cancer patients that respond to chemoradiation therapy display an intense tumor infiltrating immune profile before treatment.
Martins PR; Machado CMT; Coxir SA; de Oliveira AJ; Moreira TB; Campos LS; Alcântara R; de Paula SOC; de Oliveira Salles PG; Gollob KJ; Magalhães WCS
Exp Mol Pathol; 2019 Dec; 111():104314. PubMed ID: 31654628
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis.
Kfouri CFDA; Lombardi W; Romania MCFN; Puls ML; Martins-Ferreira RA; Lombardi LB; Andrade JM
Rev Col Bras Cir; 2019 Feb; 46(1):e2077. PubMed ID: 30785571
[TBL] [Abstract] [Full Text] [Related]
15. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract] [Full Text] [Related]
16. Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial.
Zhou JG; Zhou NJ; Zhang Q; Feng YY; Zhou H
Trials; 2018 Sep; 19(1):500. PubMed ID: 30223869
[TBL] [Abstract] [Full Text] [Related]
17. Anti-tumor effect of emodin on gynecological cancer cells.
Wang Y; Yu H; Zhang J; Ge X; Gao J; Zhang Y; Lou G
Cell Oncol (Dordr); 2015 Oct; 38(5):353-63. PubMed ID: 26162964
[TBL] [Abstract] [Full Text] [Related]
18. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.
Semenisty V; Naroditsky I; Keidar Z; Bar-Sela G
BMC Cancer; 2015 May; 15():402. PubMed ID: 25967676
[TBL] [Abstract] [Full Text] [Related]
19. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract] [Full Text] [Related]
20. Rational design of cancer-targeted BSA protein nanoparticles as radiosensitizer to overcome cancer radioresistance.
Huang Y; Luo Y; Zheng W; Chen T
ACS Appl Mater Interfaces; 2014; 6(21):19217-28. PubMed ID: 25314331
[TBL] [Abstract] [Full Text] [Related]
[Next]
